Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -33.15%29.64M | -12.43%10.73M | 4.80%44.33M | 16.94%12.25M | -25.26%42.31M | -48.62%10.48M | -18.28%56.6M | -17.64%20.39M | 3.92%69.26M | 18.90%24.75M |
| Operating income | -33.15%29.64M | -12.43%10.73M | 4.80%44.33M | 16.94%12.25M | -25.26%42.31M | -48.62%10.48M | -18.28%56.6M | -17.64%20.39M | 3.92%69.26M | 18.90%24.75M |
| Cost of sales | 32.43%-12.7M | 21.63%-3.4M | 19.80%-18.79M | -2.41%-4.34M | -26.15%-23.43M | -2.61%-4.24M | 24.41%-18.57M | 30.83%-4.13M | -37.95%-24.57M | -45.21%-5.97M |
| Operating expenses | 32.43%-12.7M | 21.63%-3.4M | 19.80%-18.79M | -2.41%-4.34M | -26.15%-23.43M | -2.61%-4.24M | 24.41%-18.57M | 30.83%-4.13M | -37.95%-24.57M | -45.21%-5.97M |
| Gross profit | -33.67%16.94M | -7.39%7.32M | 35.33%25.54M | 26.82%7.91M | -50.37%18.87M | -61.64%6.24M | -14.91%38.03M | -13.44%16.26M | -8.50%44.69M | 12.42%18.78M |
| Employee expense | 3.16%-13.75M | -12.17%-6.04M | 0.60%-14.2M | 22.75%-5.38M | -1.99%-14.28M | 4.76%-6.97M | 3.03%-14M | 8.15%-7.32M | -36.36%-14.44M | -101.90%-7.97M |
| Revaluation surplus | -587.99%-22.62M | ---- | 88.74%-3.29M | ---- | 26.82%-29.2M | -1,521.31%-24.27M | -465.70%-39.9M | -114.14%-1.5M | 70.83%10.91M | 148.92%10.58M |
| -Changes in the fair value of investment property | -587.99%-22.62M | ---- | 88.74%-3.29M | ---- | 26.82%-29.2M | -1,521.31%-24.27M | -465.70%-39.9M | -114.14%-1.5M | 70.83%10.91M | 148.92%10.58M |
| Impairment and provision | -394.40%-4.94M | ---- | 13.04%-1M | ---- | 97.54%-1.15M | ---- | -2,480.34%-46.73M | -4,463.33%-1.37M | -1,716.96%-1.81M | -110.00%-30K |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---3.24M | ---- | ---- | ---- |
| -Other impairment is provision | -394.40%-4.94M | ---- | 13.04%-1M | ---- | 97.36%-1.15M | ---- | -2,301.44%-43.49M | -4,463.33%-1.37M | -1,716.96%-1.81M | -110.00%-30K |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.43%-11.77M | ---23.38M | ---11.27M |
| Special items of operating profit | 4.23%-12.24M | 15.29%-4.72M | -2.53%-12.78M | 30.75%-5.57M | -249.82%-12.46M | -196.23%-8.05M | 353.52%8.32M | 224.91%8.36M | 79.46%-3.28M | -7.00%-6.69M |
| Operating profit | -540.30%-36.61M | -12.70%-3.43M | 85.04%-5.72M | 90.78%-3.05M | 29.60%-38.22M | -1,342.44%-33.05M | -527.80%-54.29M | -21.79%2.66M | -55.89%12.69M | -69.24%3.4M |
| Financing cost | 30.11%-15.62M | 40.41%-7.79M | 19.84%-22.35M | 1.67%-13.08M | -17.76%-27.89M | ---13.3M | ---23.68M | ---- | ---- | ---- |
| Share of profit from joint venture company | 26.66%-3.83M | 39.83%-1.17M | -191.64%-5.22M | 30.92%-1.95M | 183.80%5.69M | -244.80%-2.82M | -3,533.69%-6.8M | ---817K | ---187K | ---- |
| Earning before tax | -68.39%-56.06M | 31.39%-12.4M | 44.90%-33.29M | 63.25%-18.07M | 28.73%-60.41M | -2,767.55%-49.16M | -777.94%-84.76M | -45.81%1.84M | 18.67%12.5M | 94.79%3.4M |
| Tax | 226.21%4.89M | 97.98%-2K | -130.37%-3.88M | -101.69%-99K | -19.84%12.76M | 482.11%5.85M | 324.76%15.92M | 49.61%-1.53M | -11.96%-7.08M | -78.19%-3.04M |
| After-tax profit from continuing operations | -37.67%-51.16M | 31.76%-12.4M | 22.00%-37.17M | 58.05%-18.17M | 30.79%-47.65M | -14,025.72%-43.31M | -1,370.36%-68.84M | -13.85%311K | 28.75%5.42M | 802.50%361K |
| After-tax profit from non-continuing business | ---- | ---- | 162,808.33%19.55M | ---- | --12K | ---- | ---- | ---- | ---- | ---- |
| Special items of earning after tax | ---- | ---- | 162,808.33%19.55M | ---- | --12K | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | -190.44%-51.16M | 31.76%-12.4M | 63.02%-17.62M | 58.05%-18.17M | 30.80%-47.64M | -14,025.72%-43.31M | -1,370.36%-68.84M | -13.85%311K | 28.75%5.42M | 802.50%361K |
| Minority shareholders should account for profits from continuing business | -225.93%-7.56M | ---- | -640.58%-2.32M | ---- | ---313K | ---- | ---- | ---- | ---- | ---- |
| Minority shareholders should account for non-continuing business profits | ---- | ---- | 1,300.00%14K | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
| Minority profit | -227.91%-7.56M | 23.24%-2.89M | -638.46%-2.3M | 31.89%-3.77M | 94.12%-312K | -97.01%-5.53M | -80.43%-5.31M | 11.08%-2.81M | -265.90%-2.94M | -119.53%-3.16M |
| Shareholders should account for profits from continuing business | -25.14%-43.61M | ---- | 26.38%-34.85M | ---- | ---47.34M | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | 177,490.91%19.54M | ---- | --11K | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -184.80%-43.61M | 33.98%-9.51M | 67.64%-15.31M | 61.88%-14.4M | 25.51%-47.32M | -1,310.74%-37.78M | -859.76%-63.53M | -11.36%3.12M | 243.41%8.36M | 138.00%3.52M |
| Basic earnings per share | -185.62%-0.0437 | 34.03%-0.0095 | 67.72%-0.0153 | 61.90%-0.0144 | 25.47%-0.0474 | -1,319.35%-0.0378 | -736.00%-0.0636 | -45.61%0.0031 | 122.22%0.01 | 90.00%0.0057 |
| Diluted earnings per share | -185.62%-0.0437 | 34.03%-0.0095 | 67.72%-0.0153 | 61.90%-0.0144 | 25.47%-0.0474 | -1,319.35%-0.0378 | -736.00%-0.0636 | -45.61%0.0031 | 122.22%0.01 | 90.00%0.0057 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.